Logo image of TLGT

Teligent Inc (TLGT) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:TLGT -

0.1735
-0.03 (-13.85%)
Last: 10/15/2021, 8:08:54 PM
0.1717
0 (-1.04%)
After Hours: 10/15/2021, 8:08:54 PM

TLGT Key Statistics, Chart & Performance

Key Statistics
Market Cap16.10M
Revenue(TTM)46.30M
Net Income(TTM)-91.57M
Shares92.82M
Float77.37M
52 Week High1.6
52 Week Low0.17
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-7.24
PEN/A
Fwd PE0.04
Earnings (Next)03-01
IPO1981-07-30
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
TLGT short term performance overview.The bars show the price performance of TLGT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

TLGT long term performance overview.The bars show the price performance of TLGT in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of TLGT is 0.1735 null. In the past month the price decreased by -55.51%. In the past year, price decreased by -75.14%.

Teligent Inc / TLGT Daily stock chart

TLGT Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

TLGT Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to TLGT. While TLGT seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TLGT Financial Highlights

Over the last trailing twelve months TLGT reported a non-GAAP Earnings per Share(EPS) of -7.24. The EPS increased by 27.02% compared to the year before.


Industry RankSector Rank
PM (TTM) -197.78%
ROA -101.27%
ROE N/A
Debt/Equity -2.67
Chartmill High Growth Momentum
EPS Q2Q%90.91%
Sales Q2Q%-23.21%
EPS 1Y (TTM)27.02%
Revenue 1Y (TTM)-16.53%

TLGT Forecast & Estimates

For the next year, analysts expect an EPS growth of 131.61% and a revenue growth -16.85% for TLGT


Analysts
Analysts0
Price TargetN/A
EPS Next Y131.61%
Revenue Next Year-16.85%

TLGT Ownership

Ownership
Inst Owners12.88%
Ins Owners0.36%
Short Float %N/A
Short RatioN/A

About TLGT

Company Profile

TLGT logo image Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. The company is headquartered in Buena, New Jersey and currently employs 142 full-time employees. The firm is focused on the development, manufacturing and marketing of a portfolio of generic pharmaceutical products under its own label and private label for other pharmaceutical companies in topical, injectable, complex and other dosage forms. The company also provides contract development and manufacturing services to the prescription and over-the-counter (OTC) pharmaceutical and cosmetic markets. Under the Company's own label, it markets and sells generic topical, and generic and branded generic injectable pharmaceutical products in the United States and Canada. In the United States, the Company markets approximately 37 generic topical pharmaceutical products and one branded injectable pharmaceutical product. In Canada, it markets approximately 24 generic injectable, one generic topical and three generic ophthalmic products.

Company Info

Teligent Inc

105 Lincoln Avenue

Buena NEW JERSEY 08310 US

CEO: Timothy B. Sawyer

Employees: 142

TLGT Company Website

Phone: 18566971441.0

Teligent Inc / TLGT FAQ

What does TLGT do?

Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. The company is headquartered in Buena, New Jersey and currently employs 142 full-time employees. The firm is focused on the development, manufacturing and marketing of a portfolio of generic pharmaceutical products under its own label and private label for other pharmaceutical companies in topical, injectable, complex and other dosage forms. The company also provides contract development and manufacturing services to the prescription and over-the-counter (OTC) pharmaceutical and cosmetic markets. Under the Company's own label, it markets and sells generic topical, and generic and branded generic injectable pharmaceutical products in the United States and Canada. In the United States, the Company markets approximately 37 generic topical pharmaceutical products and one branded injectable pharmaceutical product. In Canada, it markets approximately 24 generic injectable, one generic topical and three generic ophthalmic products.


Can you provide the latest stock price for Teligent Inc?

The current stock price of TLGT is 0.1735 null. The price decreased by -13.85% in the last trading session.


What is the dividend status of Teligent Inc?

TLGT does not pay a dividend.


How is the ChartMill rating for Teligent Inc?

TLGT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What sector and industry does Teligent Inc belong to?

Teligent Inc (TLGT) operates in the Health Care sector and the Pharmaceuticals industry.


Should I buy TLGT stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on TLGT.